Cargando…
Perioperative Treatment in Resectable Gastric Cancer: Current Perspectives and Future Directions
Gastric cancer (GC) is the fifth-most common cancer worldwide and an important cause of cancer-related-death. The growing knowledge of its molecular pathogenesis has shown that GC is not a single entity, but a constellation of different diseases, each with its own molecular and clinical characterist...
Autores principales: | Petrillo, Angelica, Pompella, Luca, Tirino, Giuseppe, Pappalardo, Annalisa, Laterza, Maria Maddalena, Caterino, Marianna, Orditura, Michele, Ciardiello, Fortunato, Lieto, Eva, Galizia, Gennaro, Castoro, Carlo, De Vita, Ferdinando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468561/ https://www.ncbi.nlm.nih.gov/pubmed/30901943 http://dx.doi.org/10.3390/cancers11030399 |
Ejemplares similares
-
What’s New in Gastric Cancer: The Therapeutic Implications of Molecular Classifications and Future Perspectives
por: Tirino, Giuseppe, et al.
Publicado: (2018) -
Durable Complete Radiological Response to Nivolumab in Two Heavily Pretreated Western Elderly Patients With Metastatic Gastric Cancer: A Case Report
por: Tirino, Giuseppe, et al.
Publicado: (2020) -
Pancreatic Cancer Molecular Classifications: From Bulk Genomics to Single Cell Analysis
por: Pompella, Luca, et al.
Publicado: (2020) -
Nivolumab in Heavily Pretreated Metastatic Gastric Cancer Patients: Real-Life Data from a Western Population
por: Petrillo, Angelica, et al.
Publicado: (2020) -
NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): from clinical trials to clinical practice
por: De Vita, Ferdinando, et al.
Publicado: (2016)